πŸ‡ΊπŸ‡Έ FDA
Patent

US 10968495

Lactobacillus reuteri and use thereof

granted A61KA61K2035/115A61K35/747

Quick answer

US patent 10968495 (Lactobacillus reuteri and use thereof) held by INFINITUS (CHINA) COMPANY LTD. expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INFINITUS (CHINA) COMPANY LTD.
Grant date
Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2035/115, A61K35/747, A61P, A61P1/00